Journal:A metabolomics and big data approach to cannabis authenticity (authentomics)

Full article title	A metabolomics and big data approach to cannabis authenticity (authentomics)
Journal	International Journal of Molecular Sciences
Author(s)	Jadhav, Pramodkumar D.; Shim, Youn Y.; Paek, Ock J.; Jeon, Jung-Tae; Park, Hyun-Je; Park, Ilbum; Park, Eui-Seong; Kim, Young J.; Reaney, Martin J.T.
Author affiliation(s)	University of Saskatchewan, Prairie Tide Diversified, Korea University, Republic of Korea Ministry of Food and Drug Safety, Yuhan Care Company
Primary contact	Email: younyoung dot shim at usask dot ca
Year published	2023
Volume and issue	24(9)
Article #	8202
DOI	10.3390/ijms24098202
ISSN	1422-0067
Distribution license	Creative Commons Attribution 4.0 International
Website	https://www.mdpi.com/1422-0067/24/9/8202
Download	https://www.mdpi.com/1422-0067/24/9/8202/pdf?version=1683269179 (PDF)

Abstract

With the increasing accessibility of cannabis (Cannabis sativa L., also known as marijuana and hemp), its products are being developed as extracts for both recreational and therapeutic use. This has led to increased scrutiny by regulatory bodies, who aim to understand and regulate the complex chemistry of these products to ensure their safety and efficacy. Regulators use targeted analyses to track the concentration of key bioactive metabolites and potentially harmful contaminants, such as heavy metals and other impurities. However, the complexity of cannabis' metabolic pathways requires a more comprehensive approach. A non-targeted metabolomic analysis of cannabis products is necessary to generate data that can be used to determine their authenticity and efficacy. An authentomics approach, which involves combining the non-targeted analysis of new samples with big data comparisons to authenticated historic datasets, provides a robust method for verifying the quality of cannabis products. To meet International Organization for Standardization (ISO) standards, it is necessary to implement authentomics platform technology and build an integrated database of cannabis analytical results. This study is the first to review the topic of the authentomics of cannabis and its potential to meet ISO standards.

Keywords: cannabis authenticity, Cannabis sativa L., authentomics, metabolites, nuclear magnetic resonance

Introduction

Metabolomics is a crucial approach for gaining insight into the largest possible set of low-molecular-weight metabolites present in biological samples. When used in conjunction with genomics, transcriptomics, and proteomics, metabolomics helps shed light on the workings of biological systems as they develop and respond to environmental stimuli.

Metabolomics is downstream of genomics, transcriptomics, and proteomics. [1,2] Comprehensive analysis of the metabolome is predicated on developments in analytical methods, data-handling tools, and database management systems that first generate big data sets using various chemometric techniques and subsequently use multivariate analysis for interpretation. [3] Nuclear magnetic resonance (NMR) and chromatography (gas or liquid) coupled with mass spectrometry (MS) are the most common techniques used in metabolomic analysis.

There are different approaches in metabolomics for the comprehensive analysis of both known and unknown metabolites. One approach, metabolic profiling, involves measuring large sets of metabolites to provide information about metabolism. Such an approach can include the characterization of both metabolites (unknown and known) and metabolic pathways. Analytical methods that focus on the repeated identification and quantification of pre-selected compounds are known as targeted approaches. On the other hand, non-targeted approaches quantify all measurable compounds, regardless of their identification. Both targeted and non-targeted methods can provide information about the concentration of known compounds, while unknown compounds can be interpreted as having relative concentrations.

A third approach, called metabolic fingerprinting, typically generates metabolic information without precise quantification and identification. This latter approach involves the production of a pattern that is, ideally, interpretable. Fingerprinting is used in food or food product authentication, where the fingerprint pattern of the unknown sample is compared with the spectral database of known samples to determine its conformity. [4,5] Metabolic studies can also be classified based on the study objectives, such as (a) informative studies, where the metabolites’ identification and quantification are obtained; (b) discriminative studies, which help to distinguish metabolites among sample populations; and (c) predictive studies, which create statistical models to create class memberships. [6]

Cannabis and its extracts are chemically complex natural mixtures with various biologically active compounds (metabolites). These compounds include phytocannabinoids, terpenoids, flavonoids, nitrogenous compounds, sugars, proteins, fatty acids, and more. (Table 1)

Table 1. Chemical constituents (metabolites) of Cannabis sativa L. (flowers) by chemical class. Chemical class 1980 [7] 1995 [8] 2005 [9] 2014 [10] 2017 [11] Cannabinoids (all) 61 66 70 104 120    CBC 4 4 5 8 9    CBD 7 7 7 8 7    CBG 6 6 7 17 16    Δ8-THC 2 2 2 2 5    Δ9-THC 9 9 9 18 23    CBE 5 5 5 5 5    CBL 3 3 3 3 3    CBN 6 7 7 10 11    CBND 2 2 2 2 2    CBT 6 9 9 9 9    Miscellaneous 11 12 14 22 30 Nitrogenous compounds 20 27 27 29 33 Amino acids 18 18 18 18 18 Proteins, enzymes, and glycoproteins 11 11 11 11 11 Sugars and related compounds 34 34 34 34 34 Hydrocarbons 50 50 50 50 50 Simple alcohols 7 7 7 7 7 Simple aldehydes 12 12 12 12 12 Simple ketones 13 13 13 13 13 Simple acids 20 20 20 20 20 Fatty acids 12 23 23 27 27 Simple esters and lactones 13 13 13 13 13 Steroids 11 11 11 15 15 Terpenes 103 120 120 120 120 Non-cannabinoid phenols 16 25 25 33 33 Flavonoids 19 21 23 27 27 Vitamins 1 1 1 1 1 Pigments 2 2 2 2 2 Elements 0 9 9 9 9

There were 423 compounds reported in the 1980s [7], and in 2017, the number of identified compounds increased to ~565 [11], and more are being identified. The number of cannabinoids detected is now over 120. [8,9,10,11] Among these cannabinoids, psychoactive Δ⁹-tetrahydrocannabinol (THC) and cannabidiol (CBD) are best known for their contribution to pharmacological activity (Figure 1). These compounds are not the products of metabolic pathways but rather are produced as acidic precursors. The action of heat on these precursors induces decarboxylation and the formation of bioactive compounds. Cannabis extracts contain a range of compounds, including cannabinoids and terpenes, of which many contribute a synergistic “entourage effect” where the therapeutic effect is greater than the sum of the individual compounds. [12] While the U.S. Food and Drug Administration (FDA)-approved drugs such as Epidiolex, Marinol, Syndros, and Cesamet have demonstrated efficacy in treating certain ailments, there is still a great deal of potential for the use of cannabinoids in treating other conditions. Current research suggests that cannabinoids may have anti-inflammatory, analgesic, and anxiolytic properties, among others. However, further clinical trials are needed to fully understand the therapeutic potential of these compounds and mixtures of compounds. Interestingly, cannabinoids bind to receptors and exert biological effects. [13] As one might expect, one class of receptors—cannabinoid receptors—was identified through their interaction with cannabinoids.

Fig. 1. Chemical structures of Δ9-THC and CBD.

Notes

This presentation is faithful to the original, with only a few minor changes to presentation. Some grammar and punctuation was cleaned up to improve readability. In some cases important information was missing from the references, and that information was added.